Trials / Active Not Recruiting
Active Not RecruitingNCT05818150
GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)
Multicenter, PrOspective, Randomized, Controlled Trial Comparing GenIcular Artery EmbOlization Using Embosphere Microspheres to Corticosteroid iNjections for the Treatment of Symptomatic Knee Osteoarthritis: MOTION Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 264 (estimated)
- Sponsor
- Merit Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter, prospective, interventional trial is designed to assess the outcome of subjects with symptomatic knee osteoarthritis (OA) that are randomized to treatment with either genicular artery embolization (GAE) using Embosphere Microspheres or steroid injection over a period of 24 months.
Detailed description
This study is an IDE study. It is an RCT comparing GAE to steroid injection in the knee to treat knee osteoarthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Embosphere Microspheres | Embolic Agent: Embosphere Microspheres |
| DRUG | Corticosteroid injection | Corticosteroid injection |
Timeline
- Start date
- 2024-01-16
- Primary completion
- 2026-04-01
- Completion
- 2027-10-01
- First posted
- 2023-04-18
- Last updated
- 2025-10-24
Locations
27 sites across 6 countries: United States, Australia, Brazil, Canada, New Zealand, United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05818150. Inclusion in this directory is not an endorsement.